What is the Share Price of Biofil Chemicals Pharmaceuticals Ltd?

Biofil Chemicals Pharmaceuticals Ltd share price is ₹70.50 As on 07 October, 2024|13:38

Home
>
Stocks
>
Biofil Chemicals Pharmaceuticals Ltd

Biofil Chemicals Pharmaceuticals Ltd

Q: What is the Market Cap of Biofil Chemicals Pharmaceuticals Ltd?

The Market Cap of Biofil Chemicals Pharmaceuticals Ltd is ₹127 As on 07 October, 2024|13:38

Q: What is PE Ratio of Biofil Chemicals Pharmaceuticals Ltd?

The P/E ratio of Biofil Chemicals Pharmaceuticals Ltd is 201 As on 07 October, 2024|13:38

Q: What is PB Ratio of Biofil Chemicals Pharmaceuticals Ltd?

The PB ratio of Biofil Chemicals Pharmaceuticals Ltd is 6.29 As on 07 October, 2024|13:38

₹ 70.50 -7.48 (-9.59%)
Updated on 07-10-2024 1:38 PM

Stock Rating

Pros 3

Cons 6

Price Performance

Day's Low
₹68.18

Day's High
₹79.05

₹ 70.5

52-w low
₹45.35

52-w high
₹91.87

70.5

Day's open
₹77.98
Previous close
₹77.980003
VWAP
₹72.62
Lower price band
₹62.38
Upper price band
₹93.57

Today's Market Action

The last traded share price of Biofil Chemicals Pharmaceuticals Ltd was 70.50 down by -9.59% on the NSE. Its last traded stock price on BSE was 70.45 down by -10.32%. The total volume of shares on NSE and BSE combined was 167,693 shares. Its total combined turnover was Rs 1.22 crores.

Medium and Long Term Market Action

Biofil Chemicals Pharmaceuticals Ltd hit a 52-week high of 91.87 on 16-09-2024 and a 52-week low of 45.35 on 26-10-2023. The stock price of Biofil Chemicals Pharmaceuticals Ltd is up by 23% over the last one month. It is up by 30.31% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

Market Cap (Cr): 127
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About

Data not available.

FAQ's

What is Share Price of Biofil Chemicals Pharmaceuticals Ltd?

What is the Market Cap of Biofil Chemicals Pharmaceuticals Ltd?

What is PE Ratio of Biofil Chemicals Pharmaceuticals Ltd?

What is PB Ratio of Biofil Chemicals Pharmaceuticals Ltd?

What is the CAGR of Biofil Chemicals Pharmaceuticals Ltd?

How to Buy Biofil Chemicals Pharmaceuticals Ltd Share?

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 183.85% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.02. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 81.69 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 338 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(07/10/2024)

Margin of Safety Index: High

100.00%

100.00% People are bullish about Biofil Chemicals Pharmaceuticals Ltd

0.00%

0.00 % People are bearish about Biofil Chemicals Pharmaceuticals Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %